$0 is the total value of DRESDNER RCM GLOBAL INVESTORS LLC /CA/ /ADV's 0 reported holdings in Q1 2002. The portfolio turnover from Q4 2001 to Q1 2002 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2002 | ||||||||
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2002-05-15
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DELTAGEN INC | April 11, 2002 | 1,244,700 | 3.5% |
| NS GROUP INC | February 15, 2002 | 1,036,450 | 5.0% |
| 3 DIMENSIONAL PHARMACEUTICALS INC | February 01, 2002 | 1,358,600 | 6.2% |
| ALLAIRE CORP | February 01, 2002 | ? | ? |
| APPLIED MOLECULAR EVOLUTION INC | February 01, 2002 | 1,559,900 | 6.6% |
| AQUILA INC | February 01, 2002 | 1,119,500 | 5.6% |
| AVANTGO INC | February 01, 2002 | 184,500 | 0.5% |
| AVANT IMMUNOTHERAPEUTICS INC | February 01, 2002 | 1,093,700 | 1.8% |
| BOSTON PRIVATE FINANCIAL HOLDINGS INC | February 01, 2002 | ? | ? |
| CELL GENESYS INC | February 01, 2002 | 425,400 | 1.2% |
View DRESDNER RCM GLOBAL INVESTORS LLC /CA/ /ADV's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2002-05-15 |
| SC 13G/A | 2002-04-11 |
| SC 13G/A | 2002-02-15 |
| 13F-HR | 2002-02-07 |
| 13F-NT | 2002-02-07 |
| SC 13G/A | 2002-02-04 |
| SC 13G | 2002-02-01 |
| SC 13G | 2002-02-01 |
| SC 13G | 2002-02-01 |
| SC 13G | 2002-02-01 |
View DRESDNER RCM GLOBAL INVESTORS LLC /CA/ /ADV's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.